Literature DB >> 14597355

Radiotherapy for head and neck cancer in elderly patients.

Clare P Schofield1, Andrew J Sykes, Nicholas J Slevin, Noor Z Z Rashid.   

Abstract

BACKGROUND AND
PURPOSE: Elderly patients with head and neck cancer may not be treated aggressively with radiotherapy, due to concerns regarding tolerance of treatment and toxicity. A retrospective study was undertaken of patients aged 80 years and over, treated by definitive radiotherapy for head and neck cancer.
MATERIAL AND METHODS: 98 patients aged 80-92 received radiotherapy for carcinoma of the head and neck between 1991 and 1995. All patients received beam directed radiotherapy with radical intent using an immobilisation shell.
RESULTS: Cancer specific survival was 59% and overall local control was 70% at 5 years. Both were significantly affected by T stage and site of disease. Cancer specific survival was comparable to that of patients aged below 80 years. Seven patients died within 6 months of the treatment. Three patients developed severe late toxicity. Metastatic disease occurred in eight patients.
CONCLUSIONS: Radiotherapy is a beneficial and well tolerated treatment in elderly patients with carcinoma of the head and neck.

Entities:  

Mesh:

Year:  2003        PMID: 14597355     DOI: 10.1016/s0167-8140(03)00249-4

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  16 in total

Review 1.  Management of head and neck cancer in elderly patients.

Authors:  Yassine Lalami; Gilberto de Castro; Chantal Bernard-Marty; Ahmad Awada
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

2.  Elderly patients with squamous cell carcinoma of the head and neck and the benefit of multimodality therapy.

Authors:  Virginia A Moye; Sindhu Chandramouleeswaran; Ni Zhao; Hyman B Muss; Mark C Weissler; David N Hayes; Jose P Zevallos
Journal:  Oncologist       Date:  2015-01-12

3.  [Preoperative radiochemotherapy for advanced oral cavity tumours : the Kiel DOSAK experience regarding curability and quality of life].

Authors:  Jürgen Schultze; Helge Schillmöller; J Camilo Roldán; Jörg Wiltfang; Bernhard Kimmig
Journal:  Mund Kiefer Gesichtschir       Date:  2006-07

Review 4.  Squamous cell carcinoma of the head and neck in the elderly.

Authors:  Jasenka Gugić; Primož Strojan
Journal:  Rep Pract Oncol Radiother       Date:  2012-08-10

5.  Push-out bond strength of fiber posts to irradiated and non-irradiated intraradicular dentin.

Authors:  Elif Delve Başer Can; Güher Barut; Vasfiye Işık; Emriye Algül; Gökhan Yaprak; Esra Can
Journal:  Clin Oral Investig       Date:  2022-08-18       Impact factor: 3.606

6.  Longitudinal oncology registry of head and neck carcinoma (LORHAN): initial supportive care findings.

Authors:  Barbara A Murphy; Amy Chen; Walter J Curran; Adam S Garden; Paul M Harari; Stuart J Wong; K Kian Ang
Journal:  Support Care Cancer       Date:  2009-03-05       Impact factor: 3.603

Review 7.  Combined modality therapy in the elderly population.

Authors:  Lilie L Lin; Stephen M Hahn
Journal:  Curr Treat Options Oncol       Date:  2009-06-09

8.  Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy.

Authors:  Ronald J Maggiore; Emily K Curran; Mary Ellyn Witt; Daniel J Haraf; Everett E Vokes; Ezra E W Cohen
Journal:  J Geriatr Oncol       Date:  2013-06-10       Impact factor: 3.599

Review 9.  Treatment of older patients with head and neck cancer: a review.

Authors:  Noam A VanderWalde; Mary Fleming; Jared Weiss; Bhishamjit S Chera
Journal:  Oncologist       Date:  2013-05-01

10.  Radiation-induced toxicities and outcomes after radiotherapy are independent of patient age in elderly salivary gland cancer patients: results from a matched-pair analysis of a rare disease.

Authors:  Alexander Rühle; Sofie Rothhaar; Erik Haehl; Tobias Kalckreuth; Tanja Sprave; Raluca Stoian; Constantinos Zamboglou; Eleni Gkika; Andreas Knopf; Anca-Ligia Grosu; Nils H Nicolay
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-30       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.